+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Lung Cancer Surgery Market by Approach, Product Type, Cancer Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 191 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674625
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The lung cancer surgery market is evolving rapidly as healthcare providers seek innovative, minimally invasive solutions to improve patient outcomes and address cost and policy pressures. For senior decision-makers, understanding this sector’s dynamics is essential for navigating procurement, investment, and growth opportunities.

Market Snapshot: Lung Cancer Surgery Market Growth

The lung cancer surgery market grew from USD 6.01 billion in 2024 to USD 6.38 billion in 2025. It is projected to expand at a compound annual growth rate (CAGR) of 5.95%, reaching USD 8.50 billion by 2030. Driven by the adoption of less invasive surgical methods and the integration of advanced technologies, this trajectory reflects sustained global demand, evolving treatment paradigms, and persistent cost containment challenges. The sector’s momentum is underpinned by ongoing shifts in surgical techniques, policy updates, and the need for improved patient experiences.

Scope & Segmentation: Comprehensive Market Coverage

This report offers an in-depth analysis of the entire lung cancer surgery ecosystem, categorizing the market across procedure, product, cancer type, end user, and region to empower strategic decisions.

  • Procedure Approaches: Minimally invasive surgery (robotic-assisted thoracic surgery—featuring leading systems such as Da Vinci—and video-assisted thoracoscopic surgery, including multiportal and uniportal techniques). Open surgery methods also included.
  • Product Types: Access devices and trocars; endoscopes and visualization systems; energy devices (advanced bipolar, electrosurgical, ultrasonic); stapling devices (manual and powered staplers).
  • Cancer Types: Non small cell lung cancer (adenocarcinoma, large cell carcinoma, squamous cell carcinoma) and small cell lung cancer, addressing unique surgical considerations.
  • End Users: Ambulatory surgical centers and hospitals, each with distinct requirements and care delivery models.
  • Regions: Americas (notably the U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including key nations such as the UK, Germany, Saudi Arabia, South Africa), and Asia-Pacific (e.g., China, India, Australia, Japan).
  • Leading Companies: Intuitive Surgical, Medtronic, Johnson & Johnson, Stryker, Olympus, KARL STORZ, Becton Dickinson, Boston Scientific, Smith & Nephew, Zimmer Biomet.

Lung Cancer Surgery Market: Key Takeaways

  • The shift to minimally invasive procedures, such as robotic-assisted and video-assisted surgeries, is accelerating due to growing patient demand for shorter recovery times and reduced postoperative complications.
  • Multi-disciplinary care pathways that integrate imaging, genomic profiling, and rehabilitation are helping healthcare providers optimize outcomes and tailor interventions.
  • Product innovation is focused on modular instrument designs and advanced visualization, giving providers greater precision and real-time analytics capabilities during surgery.
  • The market is witnessing active collaboration between healthcare institutions and medtech manufacturers to co-develop next-generation tools, increasing the pace and agility of adoption.
  • Major hospital systems and ambulatory centers are adopting complementary procurement strategies, including negotiating value-based agreements and exploring device reprocessing to bridge capability gaps.
  • Regional adoption rates and reimbursement policies remain variable, with some geographies emphasizing evaluation pathways for novel devices while others focus on infrastructure expansion or cost control.

Impact of 2025 US Tariffs on Lung Cancer Surgery Equipment

Starting in early 2025, new tariffs on medical imports in the United States have increased procurement complexity for hospitals and suppliers. Stakeholders are actively reassessing supply chains and seeking alternative sourcing, local manufacturing partnerships, and flexible pricing structures. For healthcare organizations expanding minimally invasive programs, the additional cost burden is driving a renewed focus on outcome-based contracting, careful budget forecasting, and the adoption of device reprocessing approaches without compromising care quality. These tariff-related pressures are reshaping supplier relationships and long-term capital investments for surgical infrastructure.

Methodology & Data Sources

The report integrates rigorous secondary research—reviewing peer-reviewed journals, regulatory filings, and health economics papers—with qualitative insights from interviews with thoracic surgeons, procurement leaders, and sector experts. Analysis is guided by thematic coding and validated through internal workshops, ensuring reliability and actionable perspectives.

Why This Report Matters for Decision-Makers

  • Offers a holistic, segmented view of the lung cancer surgery landscape to support strategic planning, procurement, and competitive positioning.
  • Provides actionable intelligence on evolving technologies, regulatory shifts, and market innovations to mitigate risk in fast-changing environments.
  • Highlights regional nuances and supply chain challenges to inform expansion, investment, and partnership strategies.

Conclusion

The lung cancer surgery market is shaped by innovation, economic forces, and evolving care models. Decisions grounded in deep market insight help organizations capture opportunity, manage complexity, and advance patient outcomes worldwide.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Lung Cancer Surgery Market, by Approach
8.1. Introduction
8.2. Minimally Invasive
8.2.1. Robotic Assisted Thoracic Surgery (Rats)
8.2.1.1. Da Vinci Systems
8.2.2. Video Assisted Thoracoscopic Surgery (Vats)
8.2.2.1. Multiportal
8.2.2.2. Uniportal
8.3. Open Surgery
9. Lung Cancer Surgery Market, by Product Type
9.1. Introduction
9.2. Access Devices and Trocars
9.3. Endoscopes and Visualization Systems
9.4. Energy Devices
9.4.1. Advanced Bipolar Devices
9.4.2. Electrosurgical Devices
9.4.3. Ultrasonic Energy Devices
9.5. Stapling Devices
9.5.1. Manual Staplers
9.5.2. Powered Staplers
10. Lung Cancer Surgery Market, by Cancer Type
10.1. Introduction
10.2. Non Small Cell Lung Cancer
10.2.1. Adenocarcinoma
10.2.2. Large Cell Carcinoma
10.2.3. Squamous Cell Carcinoma
10.3. Small Cell Lung Cancer
11. Lung Cancer Surgery Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
12. Americas Lung Cancer Surgery Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Lung Cancer Surgery Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Lung Cancer Surgery Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Intuitive Surgical, Inc.
15.3.2. Medtronic plc
15.3.3. Johnson & Johnson
15.3.4. Stryker Corporation
15.3.5. Olympus Corporation
15.3.6. KARL STORZ SE & Co. KG
15.3.7. Becton Dickinson and Company
15.3.8. Boston Scientific Corporation
15.3.9. Smith & Nephew plc
15.3.10. Zimmer Biomet Holdings, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. LUNG CANCER SURGERY MARKET MULTI-CURRENCY
FIGURE 2. LUNG CANCER SURGERY MARKET MULTI-LANGUAGE
FIGURE 3. LUNG CANCER SURGERY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2024 VS 2030 (%)
FIGURE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. LUNG CANCER SURGERY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. LUNG CANCER SURGERY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. LUNG CANCER SURGERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL LUNG CANCER SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY DA VINCI SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 11. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MULTIPORTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY UNIPORTAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 15. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY OPEN SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ACCESS DEVICES AND TROCARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENDOSCOPES AND VISUALIZATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ADVANCED BIPOLAR DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ELECTROSURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ULTRASONIC ENERGY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY MANUAL STAPLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY POWERED STAPLERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY ADENOCARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY LARGE CELL CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SQUAMOUS CELL CARCINOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY SMALL CELL LUNG CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL LUNG CANCER SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 42. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 43. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES LUNG CANCER SURGERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. CANADA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 62. CANADA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 63. CANADA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 64. CANADA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 65. CANADA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. CANADA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 67. CANADA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 68. CANADA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 69. CANADA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 70. CANADA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 72. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 73. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 74. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 75. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 77. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 78. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 80. MEXICO LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 84. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 85. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA LUNG CANCER SURGERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 122. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 123. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 124. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 125. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 126. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 128. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 129. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 130. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 131. GERMANY LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 133. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 134. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 135. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 136. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 137. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 138. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 139. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 140. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 141. FRANCE LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 145. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 146. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 152. ITALY LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 153. ITALY LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 154. ITALY LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 155. ITALY LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 156. ITALY LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 157. ITALY LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 158. ITALY LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 159. ITALY LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 160. ITALY LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 161. ITALY LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 163. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 164. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 165. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 166. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 168. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 169. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 171. SPAIN LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 182. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 183. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 193. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 203. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 204. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 205. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 206. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 208. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 209. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 210. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 211. DENMARK LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 212. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 213. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 222. QATAR LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 223. QATAR LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 224. QATAR LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 225. QATAR LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 226. QATAR LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. QATAR LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 228. QATAR LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 229. QATAR LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 230. QATAR LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 231. QATAR LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 232. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 233. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 234. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 235. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 236. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 237. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 238. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 239. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 240. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 241. FINLAND LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 242. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 243. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 245. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 246. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 252. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 253. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 255. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 256. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 262. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 263. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 264. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 265. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 266. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 267. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 268. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 269. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 270. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 271. EGYPT LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 272. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 273. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 274. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 275. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 276. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 277. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 278. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 279. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 280. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 281. TURKEY LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 283. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 285. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 286. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 293. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 294. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 295. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 296. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 297. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 298. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 299. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 300. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 301. NORWAY LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 302. POLAND LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 303. POLAND LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 304. POLAND LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 305. POLAND LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 306. POLAND LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 307. POLAND LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 308. POLAND LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 309. POLAND LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 310. POLAND LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 311. POLAND LUNG CANCER SURGERY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY APPROACH, 2018-2030 (USD MILLION)
TABLE 313. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY MINIMALLY INVASIVE, 2018-2030 (USD MILLION)
TABLE 314. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY ROBOTIC ASSISTED THORACIC SURGERY (RATS), 2018-2030 (USD MILLION)
TABLE 315. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY VIDEO ASSISTED THORACOSCOPIC SURGERY (VATS), 2018-2030 (USD MILLION)
TABLE 316. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY ENERGY DEVICES, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY STAPLING DEVICES, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY CANCER TYPE, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND LUNG CANCER SURGERY MARKET SIZE, BY END USER

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Lung Cancer Surgery market report include:
  • Intuitive Surgical, Inc.
  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Olympus Corporation
  • KARL STORZ SE & Co. KG
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Smith & Nephew plc
  • Zimmer Biomet Holdings, Inc.

Table Information